Viking Therapeutics, Inc. (0VQA.L)
USD 39.07
(-17.95%)
USD 39.07
(-17.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 292 Thousand | 291 Thousand | 296 Thousand | 277 Thousand | 260 Thousand | - |
| Gross Profit | -292 Thousand | -291 Thousand | -296 Thousand | -277 Thousand | -260 Thousand | - |
| Operating Expenses | 100.82 Million | 70.35 Million | 55.68 Million | 42.66 Million | 32.68 Million | 26.16 Million |
| Selling, General and Administrative Expenses | 37.02 Million | 16.12 Million | 10.7 Million | 10.73 Million | 9.12 Million | 7.12 Million |
| Research and Development Expenses | 63.8 Million | 54.23 Million | 44.98 Million | 31.93 Million | 23.55 Million | 19.04 Million |
| Other Expenses | - | - | - | - | - | 1.39 Million |
| Cost and Expenses | 100.82 Million | 70.35 Million | 55.68 Million | 42.66 Million | 32.68 Million | 26.16 Million |
| Operating Income | -100.82 Million | -70.35 Million | -55.68 Million | -42.66 Million | -32.68 Million | -26.16 Million |
| Interest Expense | 88 Thousand | - | 18 Thousand | 106 Thousand | 146 Thousand | 404 Thousand |
| Income Tax Expense | - | -1.48 Million | -988 Thousand | -3.44 Million | 6.99 Million | -2.71 Million |
| Earnings before Tax | -85.89 Million | -68.86 Million | -54.99 Million | -39.49 Million | -25.77 Million | -22.06 Million |
| Net Income | -85.89 Million | -67.37 Million | -54 Million | -36.05 Million | -25.77 Million | -22.06 Million |
| Earnings Per Share Basic | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 |
| Earnings Per Share Diluted | -0.91 | -0.88 | -0.70 | -0.50 | -0.36 | -0.38 |
| Weighted Average Shares Outstanding | 94.34 Million | 76.83 Million | 77.19 Million | 72.59 Million | 71.95 Million | 57.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 94.34 Million | 76.83 Million | 77.19 Million | 72.59 Million | 71.95 Million | 57.58 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -100.82 Million | -70.35 Million | -55.39 Million | -42.66 Million | -25.37 Million | 4.66 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 436 Thousand | - |
| Cost of Revenue | 87 Thousand | 75 Thousand | 74 Thousand | 292 Thousand | 74 Thousand | 73 Thousand |
| Gross Profit | -87 Thousand | -75 Thousand | -74 Thousand | -292 Thousand | 362 Thousand | -73 Thousand |
| Operating Expenses | 36.55 Million | 33.97 Million | 34.07 Million | 100.53 Million | 29.28 Million | 27.26 Million |
| Selling, General and Administrative Expenses | 13.77 Million | 10.21 Million | 9.97 Million | - | 8.78 Million | 8.88 Million |
| Research and Development Expenses | 22.78 Million | 23.76 Million | 24.1 Million | - | 20.5 Million | 18.37 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 36.55 Million | 34.05 Million | 34.07 Million | 100.82 Million | 29.28 Million | 27.26 Million |
| Operating Income | -36.55 Million | -34.05 Million | -34.07 Million | -100.82 Million | -29.28 Million | -27.26 Million |
| Interest Expense | - | - | - | 88 Thousand | 26 Thousand | 2000.00 |
| Income Tax Expense | -87 Thousand | - | 30.72 Thousand | - | 1.15 Million | -73 Thousand |
| Earnings before Tax | -24.94 Million | -22.25 Million | -27.35 Million | -85.89 Million | -24.6 Million | -22.53 Million |
| Net Income | -24.94 Million | -22.25 Million | -27.35 Million | -85.89 Million | -24.6 Million | -22.53 Million |
| Earnings Per Share Basic | -0.22 | -0.20 | -0.26 | - | -0.25 | -0.23 |
| Earnings Per Share Diluted | -0.22 | -0.20 | -0.26 | - | -0.25 | -0.23 |
| Weighted Average Shares Outstanding | 110.91 Million | 110.39 Million | 103.45 Million | 94.34 Million | 100.11 Million | 99.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 110.91 Million | 110.39 Million | 103.45 Million | 94.34 Million | 100.11 Million | 99.84 Million |
| Gross Margin | - | - | - | - | 0.83 | - |
| EBIT Margin | - | - | - | - | -67.00 | - |
| Profit Margin | - | - | - | - | -56.43 | - |
| EBITDA | -36.46 Million | -33.97 Million | -33.99 Million | - | -29.21 Million | -27.26 Million |
| Earnings Before Tax Margin | - | - | - | - | -67.17 | - |
SWEC-B
ZYDUSWELL
0HR2
HSTC
ASTRAL
AHCHY